0 followers
ProKidney (Nasdaq: PROK), a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular ther... Read more
Bruce Culleton
Mercedes Scientific
3 followers
Garuda Therapeutics
4 followers
ALS Therapy Development Institute
3 followers
CHDI Foundation
5 followers
AvaSure Holdings
1 follower
Semler Scientific
1 follower
REVOLUTION Medicines
5 followers
TytoCare
4 followers
C4 Therapeutics
4 followers
Atomica
1 follower
Revvity
5 followers
Explore companies